Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
FDA recognizes the critical unmet medical need for new, effective treatments for amyotrophic lateral sclerosis (ALS). We are committed to working with drug companies and................... 
No comment yet.
Sign up to comment
Scoop.it!
In a huge victory for ALS sufferers, FDA granted Genervon Biopharmaceuticals a fast track designation for its first in class highly effective multi-target master regulator biotechnology drug GM604 for ALS.
|
|
